|
|
DSpace at RU >
Browsing by Author Flendrie, M.
Showing results 1 to 7 of 7
| Full Text | Issue Date | Title | Author(s) | | 2009 | Effectiveness and safety of TNF-alpha blocking therapy in patients with rheumatoid arthritis. | Flendrie, M. |
| 2007 | Circulating levels of the chemokine CCL18 but not CXCL16 are elevated and correlate with disease activity in rheumatoid arthritis. | Lieshout, A.W.T. van; Fransen, J.; Flendrie, M.; Eijsbouts, A.M.M.; Hoogen, F.H.J. van den, et al |
| 2007 | Titration of infliximab treatment in rheumatoid arthritis patients based on response patterns. | Flendrie, M.; Creemers, M.C.W.; Riel, P.L.C.M. van |
| 2006 | Observational study on efficacy, safety, and drug survival of anakinra in rheumatoid arthritis patients in clinical practice. | Broeder, A. den; Jong, E. de; Franssen, M.J.A.M.; Jeurissen, M.E.; Flendrie, M., et al |
| 2005 | The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis; a longitudinal observational study. | Flendrie, M.; Creemers, M.C.W.; Welsing, P.M.J.; Riel, P.L.C.M. van |
| 2005 | Door inflixmab (Remicade) geïnduceerde geneesmiddelenreactie bij een patiënte met reumatoïde artritis. | Vissers, W.H.P.M.; Jong, E.M.G.J. de; Flendrie, M.; Creemers, M.C.W. |
| 2005 | Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study. | Flendrie, M.; Vissers, W.H.P.M.; Creemers, M.C.W.; Jong, E.M.G.J. de; Kerkhof, P.C.M. van de, et al |
Showing results 1 to 7 of 7
|